drugset / Trial / NCT00591019

Use of Modafinil in the Treatment of Tinnitus

NCT00591019

Phase 1 Terminated 7 enrolled University of Arkansas
RandomizedSingle-blindTreatment

Summary

A study on the effects of the FDA approved drug Modafinil upon attention problems associated with tinnitus. This is considered to be a safe drug with few side effects. Each subject will be asked to participate in 3 sessions each lasting approximately 1 hour in which cognitive testing and recordings will be taken. The study involves each subject taking a 2- week supply of Modafinil and a 2- week supply of placebo. We hypothesize inattention related to thalamocortical dysrhythmia found in tinnitus can be reduced by Modafinil thus improving vigilance.

Timeline

Start
2006-08
Primary completion
2008-03
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Modafinil Small molecule 200 mg

Indications